NOV

NOV Inc.

53
Fundamentals41/ 100
Valuation30/ 100
Upside potential77/ 100
Risk potential13/ 100

NOV's fundamentals are mixed, but it looks expensive: trading at 43x earnings, more than twice its usual 16x. Analysts expect strong earnings growth, though they disagree widely on how much.

NOV Fundamentals

MetricStatus
Stable
Stable
Under pressure
Healthy

NOV's balance sheet is currently healthy, and its revenue and profitability are stable, but its cash flow is under pressure.

NOV PE Valuation

CHEAPFAIREXPENSIVE208x415x623x830x
CHEAPFAIREXPENSIVE208x415x623x830x
LevelPEPriceVs current
Cheap7.2x$2.94-83%
Forward15x$17.80—
Fair16x$6.49-64%
Current43x$17.80—
Expensive72x$29.59+66%

Historical ranges are pointers, not guarantees.

NOV's PE is in its expensive range at 43x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its fair range.

NOV Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Improving
Limited
Low

Analysts expect earnings and revenue growth for NOV, with profitability improving. However, they disagree widely on these estimates.

NOV Risk to reward

ScenarioChangePrice
Upside+44%$25.65
Downside-13%$15.48

Calculated from the latest close: $17.80 on Nov 12.

NOV's one-year upside scenario is about three times its downside: +44% against −13%.

NOV Earnings Per Share

Q4 2023: $2.50Q1 2024: $2.48Q2 2024: $2.66Q3 2024: $2.70Q4 2024: $1.60Q1 2025: $1.49Q2 2025: $1.21Q3 2025: $0.99Q4 2025: $0.39Q1 2026: $0.25Q2 2026: $0.27Q3 2026: $0.41Forward: $1.19
Q4 2023: $2.50Q1 2024: $2.48Q2 2024: $2.66Q3 2024: $2.70Q4 2024: $1.60Q1 2025: $1.49Q2 2025: $1.21Q3 2025: $0.99Q4 2025: $0.39Q1 2026: $0.25Q2 2026: $0.27Q3 2026: $0.41Forward: $1.19
QuarterTTM EPSYoY
Forward$1.19+190%
Q3 2026$0.41-59%
Q2 2026$0.27-78%
Q1 2026$0.25-83%
Q4 2025$0.39-76%
Q3 2025$0.99-63%
Q2 2025$1.21-55%
Q1 2025$1.49-40%
Q4 2024$1.60-36%

NOV's earnings per share have fallen from their peak: $0.41 over the past year, against $2.70 in late 2024.

NOV Quarterly Revenue

Q4 2023: $2.3BQ1 2024: $2.2BQ2 2024: $2.2BQ3 2024: $2.2BQ4 2024: $2.3BQ1 2025: $2.1BQ2 2025: $2.2BQ3 2025: $2.2BQ4 2025: $2.3BQ1 2026: $2.1BQ2 2026: $2.1BQ3 2026: $2.2B
Q4 2023: $2.3BQ1 2024: $2.2BQ2 2024: $2.2BQ3 2024: $2.2BQ4 2024: $2.3BQ1 2025: $2.1BQ2 2025: $2.2BQ3 2025: $2.2BQ4 2025: $2.3BQ1 2026: $2.1BQ2 2026: $2.1BQ3 2026: $2.2B
QuarterRevenueYoY
Q3 2026$2.2B+2.3%
Q2 2026$2.1B-2.5%
Q1 2026$2.1B-2.4%
Q4 2025$2.3B-1.3%
Q3 2025$2.2B-0.7%
Q2 2025$2.2B-1.3%
Q1 2025$2.1B-2.4%
Q4 2024$2.3B-1.5%

NOV's revenue grew through 2023 and has held roughly level since: $2.2B last quarter, up 2.3% from the same quarter a year ago.

NOV Free Cash Flow

Q4 2023: $301MQ1 2024: −$147MQ2 2024: $350MQ3 2024: $277MQ4 2024: $473MQ1 2025: $51MQ2 2025: $108MQ3 2025: $245MQ4 2025: $472MQ1 2026: −$91MQ2 2026: −$64MQ3 2026: −$47M
Q4 2023: $301MQ1 2024: −$147MQ2 2024: $350MQ3 2024: $277MQ4 2024: $473MQ1 2025: $51MQ2 2025: $108MQ3 2025: $245MQ4 2025: $472MQ1 2026: −$91MQ2 2026: −$64MQ3 2026: −$47M
QuarterFree cash flowYoY
Q3 2026-$47M-119%
Q2 2026-$64M-159%
Q1 2026-$91M-278%
Q4 2025$472M-0.2%
Q3 2025$245M-12%
Q2 2025$108M-69%
Q1 2025$51M+$198M
Q4 2024$473M+57%

NOV usually generates cash, though not every quarter: the latest was −$47M, but it generated $270M over the past year.

NOV Total Shares

Q4 2023: 397MQ1 2024: 397MQ2 2024: 397MQ3 2024: 395MQ4 2024: 396MQ1 2025: 383MQ2 2025: 376MQ3 2025: 371MQ4 2025: 375MQ1 2026: 364MQ2 2026: 362MQ3 2026: 360M
Q4 2023: 397MQ1 2024: 397MQ2 2024: 397MQ3 2024: 395MQ4 2024: 396MQ1 2025: 383MQ2 2025: 376MQ3 2025: 371MQ4 2025: 375MQ1 2026: 364MQ2 2026: 362MQ3 2026: 360M
PeriodChange %Net change
Quarterly-0.6%-2M shares
1 year-3%-11M shares
3 years-9.1%-36M shares
5 years-7%-27M shares
Available history-5.8%-22M shares

NOV has 360M diluted shares, down 3% from a year ago, with $230M in buybacks over the past year.

NOV Net Leverage

Q4 2023: 1.0xQ1 2024: 1.4xQ2 2024: 0.8xQ3 2024: 0.7xQ4 2024: 0.4xQ1 2025: 0.5xQ2 2025: 0.6xQ3 2025: 0.5xQ4 2025: 0.2xQ1 2026: 0.5xQ2 2026: 0.7xQ3 2026: 0.8x
Q4 2023: 1.0xQ1 2024: 1.4xQ2 2024: 0.8xQ3 2024: 0.7xQ4 2024: 0.4xQ1 2025: 0.5xQ2 2025: 0.6xQ3 2025: 0.5xQ4 2025: 0.2xQ1 2026: 0.5xQ2 2026: 0.7xQ3 2026: 0.8x
QuarterNet LeverageStatus
Q3 20260.8xVery low
Q2 20260.7xVery low
Q1 20260.5xVery low
Q4 20250.2xVery low
Q3 20250.5xVery low
Q2 20250.6xVery low
Q1 20250.5xVery low
Q4 20240.4xVery low

NOV's net debt is less than a year of its operating earnings (EBITDA).

NOV Weekly Momentum

MetricValueStatus
RSI41.9Neutral
Stochastic15.0Oversold

NOV's weekly RSI is 42 (neutral) and its Stochastic is 15 (oversold).

NOV PE vs Energy Sector

MetricNOVSector medianRelative
PE43x13x231% above
PE %69618 pts above

NOV is trading at 43x earnings, a 231% premium to the Energy sector's median of 13x.

NOV Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$18.95.7% below
20 week MA$19.69.3% below
50 week MA$19.16.9% below
100 week MA$16.48.6% above
200 week MA$17.52% above

NOV has slipped below its 8-, 20- and 50-week averages, though it's still 2% above its 200-week average.

NOV Yearly ROI

YearStart priceEnd priceROI
2020$24.9$13.5-46%
2021$13.5$13.5+0.1%
2022$13.5$20.7+53%
2023$20.7$20.3-2.1%
2024$20.3$14.5-29%
2025$14.5$15.6+7.9%
2026 YTD$15.6$17.8+14%

NOV has finished lower in three of the last six years. It's up 14% so far in 2026.

Give your agent the market.

Get API key